Viking Therapeutics (VKTX) Reports In-Line Q2 EPS

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.19), in-line with the analyst estimate of ($0.19).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Goldman Regional Director in US Adjusts List of Top Names
• Evercore ISI Upgrades XPO (XPO) to Outperform
• Corona-maker Constellation Brands beats estimates, shares jump 2%